CLOV vs VRCA · rev $1.37B vs rev $7.6M
Clover Health Investments Corp (CLOV) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VRCA revenue for 2024-12-31 was $7.6M. Net income was -$76.6M. Revenue was up 47.7% from 2023-12-31 to 2024-12-31. VRCA currently screens at market cap $79.7M.
CLOV currently screens at market cap $1.55B. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the CLOV and VRCA stock pages for the full models.
Not investment advice.